| Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-302,269 | 15,188 | 25,020 | 24,772 | 4,551 | -26,120 | -2,639 |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
97,112 | 66,566 | 50,045 | 30,841 | 8,139 | 3,934 | 3,842 |
Goodwill impairments | ||||||
224,966 | - | - | - | - | - | - |
Impairments of definite-lived intangible assets | ||||||
82,678 | - | 4,804 | - | - | - | - |
Share-based compensation expense | ||||||
18,172 | 7,281 | 5,412 | 3,936 | 2,871 | 886 | 915 |
Net provision for doubtful accounts | ||||||
8,660 | 9,424 | 9,534 | 5,990 | 4,045 | 873 | 605 |
Amortization of debt issuance costs | ||||||
4,733 | 2,655 | 1,176 | 963 | 366 | 204 | 85 |
Changes in fair value of contingent consideration | ||||||
3,364 | 3,675 | -8,922 | 6,724 | 6,121 | - | - |
Contingent consideration payments | ||||||
-4,239 | - | -4,174 | -3,738 | - | - | - |
Deferred income tax benefit | ||||||
-11,847 | -10,795 | 8,779 | -4,615 | -1,295 | - | - |
Impairment of non-consolidated entities | ||||||
- | - | - | 150 | - | 932 | - |
Equity loss and impairment of non-consolidated entities | ||||||
-329 | - | -4,659 | - | -6,208 | -1,055 | -267 |
Excess tax benefits related to share-based awards (Note 10) | ||||||
- | - | - | 20,805 | 3,689 | - | - |
Loss on sale or disposal of property and equipment | ||||||
- | - | - | - | - | -13 | -29 |
Change in fair value of redeemable common shares | ||||||
- | - | - | - | -9,073 | 34,348 | 6,566 |
Termination of existing stock redemption agreement | ||||||
- | - | - | - | 4,842 | - | - |
Other | ||||||
-73 | 1 | 2 | 85 | 132 | - | - |
Certain expenses paid with notes | ||||||
- | - | - | - | - | - | 480 |
Changes in operating assets and liabilities, net of business acquisition | ||||||
Accounts receivable | ||||||
2,333 | -7,735 | 15,128 | 50,771 | 43,130 | 29,774 | 23,833 |
Inventories | ||||||
3,932 | -13,813 | 44,342 | 41,657 | 50,334 | 14,109 | 13,995 |
Accounts payable | ||||||
-80,412 | 23,088 | -5,906 | 43,202 | 56,505 | 36,138 | 31,854 |
Rebates payable | ||||||
-5,479 | 1,238 | - | - | - | - | - |
Other assets and liabilities | ||||||
-5,612 | 4,615 | -367 | -34,370 | -4,173 | 2,153 | -830 |
Net cash provided by operating activities | ||||||
35,042 | 135,254 | 31,326 | 29,447 | -9,568 | 6,227 | 5,006 |
Cash flows from investing activities: | ||||||
Expenditures for property and equipment | ||||||
1,139 | 623,067 | 67,156 | 4,624 | 1,487 | 852 | 3,214 |
Expenditures for capitalized software for internal use | ||||||
10,474 | 6,652 | 6,217 | 12,021 | 9,470 | 4,679 | 1,105 |
Payments to acquire businesses, net of cash acquired | ||||||
13,070 | 3,505 | 12,595 | 293,496 | 51,599 | 10,232 | - |
Capital investments in and loans to non-consolidated entities | ||||||
- | 100 | - | 1,459 | 4,000 | 4,500 | 1,500 |
Net proceeds from sales of property and equipment | ||||||
13,448 | 5 | 1 | - | - | - | 141 |
Other | ||||||
- | - | - | -27 | -472 | 29 | - |
Net cash used in investing activities | ||||||
-11,235 | -633,319 | -85,967 | -311,573 | -66,084 | -20,292 | -4,849 |
Cash flows from financing activities: | ||||||
Net repayment of related parties' notes receivable | ||||||
- | - | - | - | - | - | 829 |
Net payments on revolving line of credit | ||||||
-11,950 | 148,995 | 39,255 | - | -62,622 | 35,602 | 23,390 |
Proceeds from long-term debt | ||||||
- | 575,000 | - | 120,000 | - | - | - |
Payments on long term debt | ||||||
85,500 | 136,000 | 6,000 | 3,000 | 25,542 | 10,540 | 7,893 |
Payments of debt issuance costs | ||||||
891 | 21,507 | 28 | 5,055 | 480 | 204 | -892 |
Proceeds from issuance of stock upon stock option exercises | ||||||
4,098 | 7,875 | 4,448 | 10,341 | - | - | - |
Contingent consideration payments | ||||||
4,330 | - | 2,681 | 3,012 | - | - | - |
Proceeds from public offering, net of transaction costs | ||||||
- | - | - | 187,988 | 130,440 | - | - |
Payments made to repurchase stock options | ||||||
- | - | - | 36,298 | 9,400 | - | -1,043 |
Excess tax benefits related to share-based awards (Note 10) | ||||||
- | - | - | 20,805 | 3,689 | - | - |
Net cash used in financing activities | ||||||
-98,573 | 574,363 | 34,994 | 291,769 | 84,500 | 23,174 | -157 |
Net decrease in cash and equivalents | ||||||
-74,766 | 76,298 | -19,647 | 9,643 | - | - | - |
Proceeds from sale of preferred stock, net of transaction costs | ||||||
- | - | - | - | 101,815 | - | - |
Payments made to repurchase common stock | ||||||
- | - | - | - | 53,400 | - | -2,851 |
Shareholder distributions | ||||||
- | - | - | - | - | 1,684 | 10,868 |
Net increase (decrease) in cash and equivalents | ||||||
- | - | - | - | 8,848 | 9,109 | - |
Supplemental disclosures of cash flow information: | ||||||
Cash paid for interest | ||||||
37,851 | 7,327 | 5,273 | - | - | - | - |
Cash paid for interest | ||||||
- | - | - | 3,949 | 2,248 | 1,793 | -1,041 |
Cash paid for income taxes | ||||||
3,520 | 5,876 | 728 | 351 | 5,924 | - | - |
Noncash investing and financing activities: | ||||||
Issuance of notes payable associated with stock and stock option redemptions | ||||||
- | - | - | - | - | - | 28,249 |
Forgiveness of note receivable | ||||||
- | - | - | - | - | - | 196 |